Robert Miller
Vermögen: 42 310 $ am 30.06.2026
Vermögen: 42 310 $ am 30.06.2026
Robert Matthew Miller is the founder of Fulcrum Pharma Plc, Artemida Pharma Ltd, and Scancell Holdings Plc.
He is currently the Medical Director at Scancell Holdings Plc, a Member at the American Society of Clinical Oncology, Inc., and a Member at the European Society for Medical Oncology.
Previously, he worked as the Director-Clinical Development at Protodigm Ltd., the Chief Medical Officer at Opsona Therapeutics Ltd., and the Chief Consultancy Physician at Aptiv Solutions, Inc. Dr. Miller holds a doctorate degree from the University of London and The Royal College of Surgeons of England.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
Foresight Enterprise VCT Plc
Foresight Enterprise VCT Plc Investment ManagersFinance Functions as a private equity fund 0,02 % | 01.06.2026 | 69 000 ( 0,02 % ) | 42 310 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SCANCELL HOLDINGS PLC | Technik-/Wissenschafts-/F&E-Leiter | 17.11.2020 |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Artemida Pharma Ltd. | Gründer | - |
| Unternehmen | Position | Ende |
|---|---|---|
Aptiv Solutions, Inc.
Aptiv Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Corporate Officer/Principal | - |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Protodigm Ltd. | Corporate Officer/Principal | - |
Fulcrum Pharma Plc
Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Provides strategic drug development and regulatory service to the pharmaceutical and biotechnology industries | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Fulcrum Pharma Plc
Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Provides strategic drug development and regulatory service to the pharmaceutical and biotechnology industries | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Health Services |
Scancell Holdings Plc
Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Protodigm Ltd. | |
The Royal College of Surgeons of England
The Royal College of Surgeons of England Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptiv Solutions, Inc.
Aptiv Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Commercial Services |
Artemida Pharma Ltd. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen